(November 30, 2017, 2:04 PM EST) -- WASHINGTON, D.C. — The Ninth Circuit U.S. Court of Appeals’ reversal of summary judgment for a drugmaker on a claim that its immunosuppressant drugs caused a young man’s death from cancer should be reviewed by the U.S. Supreme Court because the appeals court overstepped its bounds in reversing the exclusion of expert causation testimony, the drug company argues in a Nov. 20 petition for a writ of certiorari (Teva Pharmaceuticals USA, Inc. v. Stephen Wendell, et ux., No. 17-747, U.S. Sup., 2017 U.S. S. Ct. Briefs LEXIS 4571)....